Less Restrictive Medicaid Policies for Direct‐Acting Antiviral Access Are Associated With Greater Declines in Hepatocellular Carcinoma Deaths
Increased DAA access was associated with reduced HCC-related death rates. Improved HCV treatment could contribute to decreased HCC incidence and recurrence, enhance linkage to subspecialty care, and prevent liver-related decompensation.
Authors
- Paul A. Cotney (ORCID: https://orcid.org/0000-0003-1471-2423)
- Bhagyashree Behera
- Ellen W. Green (ORCID: https://orcid.org/0000-0002-2083-522X)
- Hersh Shroff (ORCID: https://orcid.org/0000-0001-7694-3898)
- Jane Giang
- Gabriel V. Lupu (ORCID: https://orcid.org/0009-0004-3135-2161)
- Oren K. Fix
- Andrew M. Moon
- Sasha Deutsch‐Link
- A. Sidney Barritt
Institutions
- University of North Carolina at Chapel Hill (US)
Publication Details
- Journal
- Cancer Medicine
- Published
- 2026-02-01
- DOI
- https://doi.org/10.1002/cam4.71624
- Primary Topic
- Hepatitis C virus research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institutes of Health